Microaxial left ventricular assist devices (LVAD) are increasingly used to support patients with cardiogenic shock; however, outcome results are limited to single-center studies …
P Reddy, I Merdler, C Zhang, M Cellamare… - The American Journal of …, 2024 - Elsevier
The benefit of mechanical circulatory support with Impella (Abiomed, Inc., Danvers, Massachusetts) for high-risk percutaneous coronary intervention (HR-PCI) is uncertain …
Background PROTECT IV is a current enrolling randomized controlled trial evaluating high- risk percutaneous coronary intervention (HR-PCI) with prophylactic Impella versus no …
More than 1 million transcatheter-based cardiovascular procedures across the spectrum of interventional cardiology are performed annually in the United States. With the expanded …
P Reddy, I Merdler, C Zhang, M Cellamare… - The American Journal of …, 2025 - Elsevier
Background The benefit of mechanical circulatory support (MCS) with Impella (Abiomed, Inc, Danvers, MA) for patients undergoing non-emergent, high-risk percutaneous coronary …
MA Khuddus, MB Basir, A Palmer, A Edidin - Journal of the Society for …, 2023 - Elsevier
Abstract Background The Aortix percutaneous mechanical circulatory support (pMCS) 18F micromechanical axial impeller–driven pump is percutaneously placed and retrieved from …
J Haschemi, D Oehler, JM Haurand, F Voss… - ASAIO …, 2024 - journals.lww.com
Percutaneous left ventricular assist devices (pVADs) may be used in patients with cardiogenic shock (CS) to stabilize hemodynamics and maintain sufficient end-organ …
V Sharma, A Arokiadoss, A Bhardwaj… - Catheterization and …, 2024 - Wiley Online Library
The Impella is a ventricular assist device (VAD) that provides circulatory assistance to patients with impaired heart function during percutaneous coronary intervention (PCI). It …
After approximately 48 hours, the patient was deemed stable for Impella removal. The groin was sterilely prepared, and the stopcock was removed to access the ProGlide sutures …